Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats

Respiratory Physiology and Neurobiology

Volumn 175, Issue 3, 2011, Pages 349-356

  Kung, Yu Chung ^a   Lin, Ching Chi ^a   Liaw, Shwu Fang ^a   Lin, Mei Wei ^a   Chang, Feng Ting ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Airway remodeling; Angiogenesis; Bronchial asthma; Bronchial hyperreactivity; Erlotinib

Indexed keywords

ACETYLCHOLINE; ALLERGEN; BETA ACTIN; CYTOKINE; ERLOTINIB; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; BROWN NORWAY RAT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GENE EXPRESSION; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SENSITIZATION; TH2 CELL;

AIRWAY REMODELING; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; IMMUNOHISTOCHEMISTRY; OVALBUMIN; PNEUMONIA; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RATS; RATS, INBRED BN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79751524429     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.12.013     Document Type: Article

References (26)

1. Bogdan S., Klämbt C. Epidermal growth factor receptor signaling. Curr. Biol. 2001, 11:R292-R295.
2. Bucchieri F., Puddicombe S.M., Lordan J.L., Richter A., Buchanan D., Wilson S.J., Ward J., Zummo G., Howarth P.H., Djukanović R., Holgate S.T., Davies D.E. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am. J. Respir. Cell Mol. Biol. 2002, 27:179-185.
3. Burgel P.R., Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004, 59:992-996.
4. Burgel P.R., Nadel J.A. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur. Respir. J. 2008, 32:1068-1081.
5. Davies D.E., Wicks J., Powell R.M., Puddicombe S.M., Holgate S.T. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 2003, 111:215-225.
6. Deshmukh H.S., Case L.M., Wesselkamper S.C., Borchers M.T., Martin L.D., Shertzer H.G., Nadel J.A., Leikauf G.D. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am. J. Respir. Crit. Care Med. 2005, 171:305-314.
7. Duan W., Kuo I.C., Selvarajan S., Chua K.Y., Bay B.H., Wong W.S. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am. J. Respir. Crit. Care Med. 2003, 167:185-192.
8. Hamilton L.M., Torres-Lozano C., Puddicombe S.M., Richter A., Kimber I., Dearman R.J., Vrugt B., Aalbers R., Holgate S.T., Djukanović R., Wilson S.J., Davies D.E. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin. Exp. Allergy 2003, 33:233-240.
9. Hur G.Y., Lee S.Y., Lee S.H., Kim S.J., Lee K.J., Jung J.Y., Lee E.J., Kang E.H., Jung K.H., Lee S.Y., Kim J.H., Shin C., Shim J.J., In K.H., Kang K.H., Yoo S.H. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp. Mol. Med. 2007, 39:367-375.
10. Kasper M., Schöbl R., Haroske G., Fischer R., Neubert F., Dimmer V., Müller M. Distribution of von Willebrand factor in capillary endothelial cells of rat lungs with pulmonary fibrosis. Exp. Toxicol. Pathol. 1996, 48:283-288.
11. Kassel K.M., Schulte N.A., Toews M.L. Modulation of epidermal growth factor receptor binding to human airway smooth muscle cells by glucocorticoids and beta2-adrenergic receptor agonists. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L693-L699.
12. Kitazaki T., Fukuda M., Soda H., Kohno S. Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports. Lung Cancer 2005, 49:125-128.
13. Lee C.G., Link H., Baluk P., Homer R.J., Chapoval S., Bhandari V., Kang M.J., Cohn L., Kim Y.K., McDonald D.M., Elias J.A. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 2004, 10:1095-1103.
14. Lin C.C., Liaw S.F., Wu K.M., Lin C.H. Effect of erythromycin on bronchial hyperreactivity and inflammation in ovalbumin-sensitized brown Norway rats. Respir. Physiol. Neurobiol. 2008, 161:267-272.
15. Lyseng-Williamson K.A. Erlotinib: a pharmacoeconomic review of its use in advanced non-small cell lung cancer. Pharmacoeconomics 2010, 28:75-92.
16. Nadel J.A., Burgel P.R. The role of epidermal growth factor in mucus production. Curr. Opin. Pharmacol. 2001, 1:254-258.
17. Nath P., Eynott P., Leung S.Y., Adcock I.M., Bennett B.L., Chung K.F. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur. J. Pharmacol. 2005, 506:273-283.
18. Pinho V., Souza D.G., Barsante M.M., Hamer F.P., De Freitas M.S., Rossi A.G., Teixeira M.M. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J. Leukoc. Biol. 2005, 77:800-810.
19. Puddicombe S.M., Polosa R., Richter A., Krishna M.T., Howarth P.H., Holgate S.T., Davies D.E. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000, 14:1362-1374.
20. Puddicombe S.M., Torres-Lozano C., Richter A., Bucchieri F., Lordan J.L., Howarth P.H., Vrugt B., Albers R., Djukanovic R., Holgate S.T., Wilson S.J., Davies D.E. Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 2003, 28:61-68.
21. Semlali A., Jacques E., Plante S., Biardel S., Milot J., Laviolette M., Boulet L.P., Chakir J. TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells. Am. J. Respir. Cell Mol. Biol. 2008, 38:202-208.
22. Takezawa J., Miller F.J., O'Neil J.J. Single-breath diffusing capacity and lung volumes in small laboratory mammals. J. Appl. Physiol. 1980, 48:1052-1059.
23. Vargaftig B.B., Singer M. Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L808-L818.
24. Wilson J.W., Hii S. The importance of the airway microvasculature in asthma. Curr. Opin. Allergy Clin. Immunol. 2006, 6:51-55.
25. Wong W.S. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr. Opin. Pharmacol. 2005, 5:264-271.
26. Zhang S., Smartt H., Holgate S.T., Roche W.R. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab. Invest. 1999, 79:395-405.